Find Research Outputs

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2011

Author

  • Thomas Geisbert
2015

A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

Mire, C. E., Geisbert, J. B., Versteeg, K. M., Mamaeva, N., Agans, K. N., Geisbert, T. W. & Connor, J. H., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S384-S388

Research output: Contribution to journalArticle

21 Scopus citations
2014

Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus

Garamszegi, S., Yen, J. Y., Honko, A. N., Geisbert, J. B., Rubins, K. H., Geisbert, T. W., Xia, Y., Hensley, L. E. & Connor, J. H., Jul 2014, In : PLoS neglected tropical diseases. 8, 7, e3061.

Research output: Contribution to journalArticle

13 Scopus citations
2013

Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever

Smith, L. M., Hensley, L. E., Geisbert, T. W., Johnson, J., Stossel, A., Honko, A., Yen, J. Y., Geisbert, J., Paragas, J., Fritz, E., Olinger, G., Young, H. A., Rubins, K. H. & Karp, C. L., Jul 15 2013, In : Journal of Infectious Diseases. 208, 2, p. 310-318 9 p.

Research output: Contribution to journalArticle

77 Scopus citations
2014

Marburg and Ebola Hemorrhagic Fevers (Filoviruses)

Geisbert, T., Aug 28 2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier Inc., Vol. 2. p. 1995-1999.e1

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations
2019

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever

Rodriguez, S. E., Cross, R. W., Fenton, K. A., Bente, D. A., Mire, C. E. & Geisbert, T. W., Dec 1 2019, In : Scientific reports. 9, 1, 7755.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations
2011

Management of accidental exposure to Ebola virus in the biosafety Level 4 Laboratory, Hamburg, Germany

Günther, S., Feldmann, H., Geisbert, T. W., Hensley, L. E., Rollin, P. E., Nichol, S. T., Ströher, U., Artsob, H., Peters, C. J., Ksiazek, T. G., Becker, S., Ter Meulen, J., Ölschläger, S., Schmidt-Chanasit, J., Sudeck, H., Burchard, G. D. & Schmiedel, S., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S785-S790

Research output: Contribution to journalArticle

103 Scopus citations
2020

Immune correlates of postexposure vaccine protection against Marburg virus

Woolsey, C., Jankeel, A., Matassov, D., Geisbert, J. B., Agans, K. N., Borisevich, V., Cross, R. W., Deer, D. J., Fenton, K. A., Latham, T. E., Gerardi, C. S., Mire, C. E., Eldridge, J. H., Messaoudi, I. & Geisbert, T. W., Dec 1 2020, In : Scientific reports. 10, 1, 3071.

Research output: Contribution to journalArticle

Open Access
2016

Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway

Pattabhi, S., Wilkins, C. R., Dong, R., Knoll, M. L., Posakony, J., Kaiser, S., Mire, C., Wang, M. L., Ireton, R. C., Geisbert, T., Bedard, K. M., Iadonato, S. P., Loo, Y. M. & Gale, M., 2016, In : Journal of Virology. 90, 5, p. 2372-2387 16 p.

Research output: Contribution to journalArticle

25 Scopus citations
2014

Vaccines and antivirals for filoviruses

Mire, C. & Geisbert, T., Jan 1 2014, Biology and Pathogenesis of Rhabdo- and Filoviruses. World Scientific Publishing Co., p. 587-620 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
2018

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever

Boisen, M. L., Hartnett, J. N., Shaffer, J. G., Goba, A., Momoh, M., Sandi, J. D., Fullah, M., Nelson, D. K. S., Bush, D. J., Rowland, M. M., Heinrich, M. L., Koval, A. P., Cross, R. W., Barnes, K. G., Lachenauer, A. E., Lin, A. E., Nekoui, M., Kotliar, D., Winnicki, S. M., Siddle, K. J. & 18 others, Gbakie, M., Fonnie, M., Koroma, V. J., Kanneh, L., Kulakosky, P. C., Hastie, K. M., Wilson, R. B., Andersen, K. G., Folarin, O. O., Happi, C. T., Sabeti, P. C., Geisbert, T. W., Saphire, E. O., Khan, S. H., Grant, D. S., Schieffelin, J. S., Branco, L. M. & Garry, R. F., Dec 1 2018, In : Scientific reports. 8, 1, 5939.

Research output: Contribution to journalArticle

10 Scopus citations
2016

Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection

Cross, R. W., Boisen, M. L., Millett, M. M., Nelson, DI. S., Oottamasathien, D., Hartnett, J. N., Jones, A. B., Goba, A., Momoh, M., Fullah, M., Bornholdt, Z. A., Fusco, M. L., Abelson, D. M., Oda, S., Brown, B. L., Pham, H., Rowland, M. M., Agans, K. N., Geisbert, J. B., Heinrich, M. L. & 14 others, Kulakosky, P. C., Shaffer, J. G., Schieffelin, J. S., Kargbo, B., Gbetuwa, M., Gevao, S. M., Wilson, R. B., Saphire, E. O., Pitts, K. R., Khan, S. H., Grant, D. S., Geisbert, T. W., Branco, L. M. & Garry, R. F., Oct 15 2016, In : Journal of Infectious Diseases. 214, p. S210-S217

Research output: Contribution to journalArticle

17 Scopus citations
2014

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody

Geisbert, T. W., Mire, C. E., Geisbert, J. B., Chan, Y. P., Agans, K. N., Feldmann, F., Fenton, K. A., Zhu, Z., Dimitrov, D. S., Scott, D. P., Bossart, K. N., Feldmann, H. & Broder, C. C., Jun 25 2014, In : Science Translational Medicine. 6, 242, 242ra82.

Research output: Contribution to journalArticle

58 Scopus citations
2020

Erratum: Correction for Satterfield et al., "Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets" (Journal of virology (2016) 90 14 (6326-6343) PII: e00059-20)

Satterfield, B. A., Cross, R. W., Fenton, K. A., Borisevich, V., Agans, K. N., Deer, D. J., Graber, J., Basler, C. F., Geisbert, T. W. & Mire, C. E., Mar 31 2020, In : Journal of virology. 94, 8

Research output: Contribution to journalComment/debate

Open Access
2016

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

Robinson, J. E., Hastie, K. M., Cross, R. W., Yenni, R. E., Elliott, D. H., Rouelle, J. A., Kannadka, C. B., Smira, A. A., Garry, C. E., Bradley, B. T., Yu, H., Shaffer, J. G., Boisen, M. L., Hartnett, J. N., Zandonatti, M. A., Rowland, M. M., Heinrich, M. L., Martinez-Sobrido, L., Cheng, B., De La Torre, J. C. & 30 others, Andersen, K. G., Goba, A., Momoh, M., Fullah, M., Gbakie, M., Kanneh, L., Koroma, V. J., Fonnie, R., Jalloh, S. C., Kargbo, B., Vandi, M. A., Gbetuwa, M., Ikponmwosa, O., Asogun, D. A., Okokhere, P. O., Follarin, O. A., Schieffelin, J. S., Pitts, K. R., Geisbert, J. B., Kulakoski, P. C., Wilson, R. B., Happi, C. T., Sabeti, P. C., Gevao, S. M., Khan, S. H., Grant, D. S., Geisbert, T. W., Saphire, E. O., Branco, L. M. & Garry, R. F., May 10 2016, In : Nature communications. 7, 11544.

Research output: Contribution to journalArticle

52 Scopus citations
2017

Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop

Mire, C. E. & Geisbert, T. W., Aug 2017, In : Trends in Molecular Medicine. 23, 8, p. 669-671 3 p.

Research output: Contribution to journalShort survey

6 Scopus citations
2013

Filoviridae: Marburg and ebola viruses

Feldmann, H., Sanchez, A. & Geisbert, T., May 21 2013, Fields Virology: Sixth Edition. Wolters Kluwer Health Adis (ESP), Vol. 1.

Research output: Chapter in Book/Report/Conference proceedingChapter

81 Scopus citations
2017

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

Versteeg, K., Menicucci, A. R., Woolsey, C., Mire, C. E., Geisbert, J. B., Cross, R. W., Agans, K. N., Jeske, D., Messaoudi, I. & Geisbert, T. W., Dec 1 2017, In : Scientific reports. 7, 1, 9730.

Research output: Contribution to journalArticle

13 Scopus citations
2014

Lassa Fever in Post-Conflict Sierra Leone

Shaffer, J. G., Grant, D. S., Schieffelin, J. S., Boisen, M. L., Goba, A., Hartnett, J. N., Levy, D. C., Yenni, R. E., Moses, L. M., Fullah, M., Momoh, M., Fonnie, M., Fonnie, R., Kanneh, L., Koroma, V. J., Kargbo, K., Ottomassathien, D., Muncy, I. J., Jones, A. B., Illick, M. M. & 31 others, Kulakosky, P. C., Haislip, A. M., Bishop, C. M., Elliot, D. H., Brown, B. L., Zhu, H., Hastie, K. M., Andersen, K. G., Gire, S. K., Tabrizi, S., Tariyal, R., Stremlau, M., Matschiner, A., Sampey, D. B., Spence, J. S., Cross, R. W., Geisbert, J. B., Folarin, O. A., Happi, C. T., Pitts, K. R., Geske, F. J., Geisbert, T. W., Saphire, E. O., Robinson, J. E., Wilson, R. B., Sabeti, P. C., Henderson, L. A., Khan, S. H., Bausch, D. G., Branco, L. M. & Garry, R. F., Mar 2014, In : PLoS neglected tropical diseases. 8, 3, e2748.

Research output: Contribution to journalArticle

88 Scopus citations
2018

Post-exposure treatments for Ebola and Marburg virus infections

Cross, R. W., Mire, C. E., Feldmann, H. & Geisbert, T. W., Jun 1 2018, In : Nature Reviews Drug Discovery. 17, 6, p. 413-434 22 p.

Research output: Contribution to journalReview article

48 Scopus citations
2011

Label-free multiplexed virus detection using spectral reflectance imaging

Lopez, C. A., Daaboul, G. G., Vedula, R. S., Özkumur, E., Bergstein, D. A., Geisbert, T. W., Fawcett, H. E., Goldberg, B. B., Connor, J. H. & Ünlü, M. S., Apr 15 2011, In : Biosensors and Bioelectronics. 26, 8, p. 3432-3437 6 p.

Research output: Contribution to journalArticle

35 Scopus citations
2017

Evaluation of medical countermeasures against ebolaviruses in nonhuman primate models

Mire, C. & Geisbert, T., 2017, Methods in Molecular Biology. Humana Press Inc., Vol. 1628. p. 293-307 15 p. (Methods in Molecular Biology; vol. 1628).

Research output: Chapter in Book/Report/Conference proceedingChapter

2013

Animal models for highly pathogenic emerging viruses

Safronetz, D., Geisbert, T. W. & Feldmann, H., Apr 2013, In : Current Opinion in Virology. 3, 2, p. 205-209 5 p.

Research output: Contribution to journalReview article

22 Scopus citations
2015

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection

Geisbert, T., Strong, J. E. & Feldmann, H., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S91-S97

Research output: Contribution to journalArticle

56 Scopus citations
2016

The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses

Pécheur, E. I., Borisevich, V., Halfmann, P., Morrey, J. D., Smee, D. F., Prichard, M., Mire, C. E., Kawaoka, Y., Geisbert, T. W. & Polyak, S. J., 2016, In : Journal of virology. 90, 6, p. 3086-3092 7 p.

Research output: Contribution to journalArticle

46 Scopus citations
2014

The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway

Edwards, M. R., Johnson, B., Mire, C. E., Xu, W., Shabman, R. S., Speller, L. N., Leung, D. W., Geisbert, T. W., Amarasinghe, G. K. & Basler, C. F., Mar 27 2014, In : Cell Reports. 6, 6, p. 1017-1025 9 p.

Research output: Contribution to journalArticle

61 Scopus citations
2019

Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization

Hastie, K. M., Cross, R. W., Harkins, S. S., Zandonatti, M. A., Koval, A. P., Heinrich, M. L., Rowland, M. M., Robinson, J. E., Geisbert, T. W., Garry, R. F., Branco, L. M. & Saphire, E. O., Aug 8 2019, In : Cell. 178, 4, p. 1004-1015.e14

Research output: Contribution to journalArticle

1 Scopus citations
2020

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys

Geisbert, J. B., Borisevich, V., Prasad, A. N., Agans, K. N., Foster, S. L., Deer, D. J., Cross, R. W., Mire, C. E., Geisbert, T. W. & Fenton, K. A., May 11 2020, In : Journal of Infectious Diseases. 221, p. S414-S418

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
2011

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with bundibugyo ebolavirus

Falzarano, D., Feldmann, F., Grolla, A., Leung, A., Ebihara, H., Strong, J. E., Marzi, A., Takada, A., Jones, S., Gren, J., Geisbert, J., Jones, S. M., Geisbert, T. W. & Feldmann, H., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S1082-S1089

Research output: Contribution to journalArticle

40 Scopus citations
2016

Monoclonal antibody therapy for junin virus infection

Zeitlin, L., Geisbert, J. B., Deer, D. J., Fenton, K. A., Bohorov, O., Bohorova, N., Goodman, C., Kim, D., Hiatt, A., Pauly, M. H., Velasco, J., Whaley, K. J., Altmann, F., Gruber, C., Steinkellner, H., Honko, A. N., Kuehne, A. I., Aman, M. J., Sahandi, S., Enterlein, S. & 3 others, Zhan, X., Enria, D. & Geisbert, T. W., Apr 19 2016, In : Proceedings of the National Academy of Sciences of the United States of America. 113, 16, p. 4458-4463 6 p.

Research output: Contribution to journalArticle

28 Scopus citations
2018

Single-dose trivalent VesiculoVax vaccine protects macaques from lethal Ebolavirus and Marburgvirus challenge

Matassov, D., Mire, C. E., Latham, T., Geisbert, J. B., Xu, R., Ota-Setlik, A., Agans, K. N., Kobs, D. J., Wendling, M. Q. S., Burnaugh, A., Rudge, T. L., Sabourin, C. L., Egan, M. A., Clarke, D. K., Geisbert, T. W. & Eldridge, J. H., Feb 1 2018, In : Journal of virology. 92, 3, e01190-17.

Research output: Contribution to journalArticle

12 Scopus citations

Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms

Warfield, K. L., Howell, K. A., Vu, H., Geisbert, J., Wong, G., Shulenin, S., Sproule, S., Holtsberg, F. W., Leung, D. W., Amarasinghe, G. K., Swenson, D. L., Bavari, S., Kobinger, G. P., Geisbert, T. & Aman, M. J., Nov 22 2018, In : The Journal of infectious diseases. 218, 5, p. S553-S564

Research output: Contribution to journalArticle

9 Scopus citations
2017

Therapeutic treatment of marburg and ravn virus infection in nonhuman primates with a human monoclonal antibody

Mire, C. E., Geisbert, J. B., Borisevich, V., Fenton, K. A., Agans, K. N., Flyak, A. I., Deer, D. J., Steinkellner, H., Bohorov, O., Bohorova, N., Goodman, C., Hiatt, A., Kim, D. H., Pauly, M. H., Velasco, J., Whaley, K. J., Crowe, J. E., Zeitlin, L. & Geisbert, T. W., Apr 5 2017, In : Science Translational Medicine. 9, 384, eaai8711.

Research output: Contribution to journalArticle

29 Scopus citations
2018

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)

Cross, R. W., Mire, C. E., Agans, K. N., Borisevich, V., Fenton, K. A. & Geisbert, T. W., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S448-S452

Research output: Contribution to journalArticle

6 Scopus citations
2020

Ebola

Campion, E. W., Feldmann, H., Sprecher, A. & Geisbert, T. W., May 7 2020, In : New England Journal of Medicine. 382, 19, p. 1832-1842 11 p.

Research output: Contribution to journalReview article

Open Access
3 Scopus citations
2015

Vesicular stomatitis virus–based vaccines against lassa and ebola viruses

Marzi, A., Feldmann, F., Geisbert, T. W., Feldmann, H. & Safronetz, D., 2015, In : Emerging infectious diseases. 21, 2, p. 305-307 3 p.

Research output: Contribution to journalArticle

39 Scopus citations

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

Thi, E. P., Mire, C., Lee, A. C. H., Geisbert, J. B., Zhou, J. Z., Agans, K. N., Snead, N. M., Deer, D. J., Barnard, T. R., Fenton, K. A., Maclachlan, I. & Geisbert, T., May 21 2015, In : Nature. 521, 7552, p. 362-365 4 p.

Research output: Contribution to journalArticle

157 Scopus citations
2019

Use of reverse genetics to inform Ebola outbreak responses

Cross, R. W. & Geisbert, T. W., Sep 2019, In : The Lancet Infectious Diseases. 19, 9, p. 925-927 3 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2016

Ebola virus vaccines – reality or fiction?

Mire, C. E., Geisbert, T. W., Feldmann, H. & Marzi, A., Nov 1 2016, In : Expert review of vaccines. 15, 11, p. 1421-1430 10 p.

Research output: Contribution to journalReview article

22 Scopus citations
2018

Marburg and Ebola Viruses - Marking 50 Years since Their Discovery

Becker, S., Feldmann, H., Geisbert, T. & Kawaoka, Y., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S1

Research output: Contribution to journalEditorial

Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates

Gilchuk, P., Mire, C. E., Geisbert, J. B., Agans, K. N., Deer, D. J., Cross, R. W., Slaughter, J. C., Flyak, A. I., Mani, J., Pauly, M. H., Velasco, J., Whaley, K. J., Zeitlin, L., Geisbert, T. W. & Crowe, J. E., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S565-S573

Research output: Contribution to journalArticle

1 Scopus citations
2013

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

Marzi, A., Engelmann, F., Feldmann, F., Haberthur, K., Shupert, W. L., Brining, D., Scott, D. P., Geisbert, T. W., Kawaoka, Y., Katze, M. G., Feldmann, H. & Messaoudi, I., Jan 29 2013, In : Proceedings of the National Academy of Sciences of the United States of America. 110, 5, p. 1893-1898 6 p.

Research output: Contribution to journalArticle

153 Scopus citations
2017

Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola Virus Makona pathogenesis

Menicucci, A. R., Versteeg, K., Woolsey, C., Mire, C. E., Geisbert, J. B., Cross, R. W., Agans, K. N., Jankeel, A., Geisbert, T. W. & Messaoudi, I., Oct 4 2017, In : Frontiers in immunology. 8, OCT, 1372.

Research output: Contribution to journalArticle

16 Scopus citations
2015

Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

Mire, C. E., Matassov, D., Geisbert, J. B., Latham, T. E., Agans, K. N., Xu, R., Ota-Setlik, A., Egan, M. A., Fenton, K. A., Clarke, D. K., Eldridge, J. H. & Geisbert, T. W., Apr 30 2015, In : Nature. 520, 7549, p. 688-691 4 p.

Research output: Contribution to journalArticle

68 Scopus citations
2016

Isolation and characterization of a novel gammaherpesvirus from a microbat cell line

Shabman, R. S., Shrivastava, S., Tsibane, T., Attie, O., Jayaprakash, A., Mire, C. E., Dilley, K. E., Puri, V., Stockwell, T. B., Geisbert, T. W., Sachidanandam, R. & Basler, C. F., Jan 1 2016, In : mSphere. 1, 1, e00070-15.

Research output: Contribution to journalArticle

10 Scopus citations
2011

Ebola haemorrhagic fever

Feldmann, H. & Geisbert, T. W., 2011, In : The Lancet. 377, 9768, p. 849-862 14 p.

Research output: Contribution to journalReview article

818 Scopus citations
2014

Viral-vectored vaccines to control pathogenic filoviruses

Mire, C. & Geisbert, T., Jul 1 2014, Novel Technologies for Vaccine Development. Springer-Verlag Wien, Vol. 9783709118184. p. 33-60 28 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
2018

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans

Cross, R. W., Speranza, E., Borisevich, V., Widen, S. G., Wood, T. G., Shim, R. S., Adams, R. D., Gerhardt, D. M., Bennett, R. S., Honko, A. N., Johnson, J. C., Hensley, L. E., Geisbert, T. W. & Connor, J. H., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S486-S495

Research output: Contribution to journalArticle

8 Scopus citations
2019

Use of single-injection recombinant vesicular stomatitis virus vaccine to protect nonhuman primates against lethal nipah virus disease

Mire, C. E., Geisbert, J. B., Agans, K. N., Versteeg, K. M., Deer, D. J., Satterfield, B. A., Fenton, K. A. & Geisbert, T. W., Jun 2019, In : Emerging infectious diseases. 25, 6, p. 1144-1152 9 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
2016

Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets

Satterfield, B. A., Cross, R. W., Fenton, K. A., Borisevich, V., Agans, K. N., Deer, D. J., Graber, J., Basler, C. F., Geisbert, T. W. & Mirea, C. E., 2016, In : Journal of virology. 90, 14, p. 6326-6343 18 p.

Research output: Contribution to journalArticle

12 Scopus citations
2011

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to ad5 and protect nonhuman primates against ebolavirus challenge

Geisbert, T. W., Bailey, M., Hensley, L., Asiedu, C., Geisbert, J., Stanley, D., Honko, A., Johnson, J., Mulangu, S., Pau, M. G., Custers, J., Vellinga, J., Hendriks, J., Jahrling, P., Roederer, M., Goudsmit, J., Koup, R. & Sullivan, N. J., May 2011, In : Journal of virology. 85, 9, p. 4222-4233 12 p.

Research output: Contribution to journalArticle

117 Scopus citations